Q2 and H1 FY27 profit growth and expansion targets disclosed

Management guided margin improvementMulti-year targets disclosedInvestor Communications View source PDF Explain this filing

GPTHEALTH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.1%Reaction day

₹144.19

prior close

₹147.48

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is usedpendingvs market: pending

Hospital peers, median of 27sector+0.0%-0.1% vs sector

On the reaction day the stock moved 0.1 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.3

10m

-1.3

15m

-1.2

30m

-1.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.1pendingpending+0.0-0.1

Next day

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 27Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The investor presentation shows unaudited Q2 FY27 operating revenue of Rs 135.6 crore, up 14.1%, EBITDA of Rs 29.8 crore, up 23.9%, and profit after tax of Rs 15.4 crore, up 45.2%. In H1, revenue rose 15.8% to Rs 261.8 crore and profit after tax rose 53.9% to Rs 28.1 crore. Occupancy improved to 50.3%. Management targets at least 70% occupancy in mature hospitals, a 1,000-bed network within two years, and long-term ROE and ROCE of about 25%.

Likely market impact

Strong profit growth, improved occupancy and expansion plans may support the stock, though new-hospital execution and occupancy gains remain key watchpoints.